The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model (Q57912004)

1

0 references

Frank Bootz

2

0 references

Patrick Imesch

3

0 references

Manuela Kaspar

4

0 references

Eveline Trachsel

Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate

5

0 references

language of work or name

English

0 references

publication date

24 June 2011

0 references

published in

Human Reproduction

0 references

volume

26

0 references

issue

9

0 references

page(s)

2344-2352

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Selective targeted delivery of TNFalpha to tumor blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Tenascins: regulation and putative functions during pathological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Endometrioma presenting as a cavitary lung mass with intense 18F-FDG uptake on PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Targeting IFN-alpha to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Diagnostic delay in women with pain and endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Endometriosis with FDG uptake on PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

The Antibody-Mediated Targeted Delivery of Interleukin-15 and GM-CSF to the Tumor Neovasculature Inhibits Tumor Growth and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Tumour vascular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Conventional medical therapies for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Preclinical safety evaluation of recombinant human interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Molecular imaging in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Antibody targeted drugs as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Design and construction of a naïve mouse antibody phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Angiogenic factors in endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

A Human mAb Specific to Oncofetal Fibronectin Selectively Targets Chronic Skin Inflammation In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

Multiplexed particle-based flow cytometric assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195

New drugs in development for the treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER195